Vivani Medical, Inc.
- VANI
- NASDAQ
- Biotechnology
- Implantable Drug Delivery
- Chronic Disease Therapeutics
$1.12
Today −2.61%Quote Oct 16, 2026, 08:00 PM UTC
−7.44%over the last month
Max drawdown −11.8%From 1-month high −11.8%3 months −17.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$101.0M
Quote Oct 16
Next earnings
Nov 12
Expected, not confirmed
Analyst target
$4.00
+257.1% from here
Floor
$1.11
0.9% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about VANIPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
42